NKE is the only that comes up on my radar for next week (announces on Tuesday after market close). While it has an implied rank of 72, its 30-day isn't exactly "doing it" at 29%. That being said, the slightly short delta, 68% probability of profit, Oct 19th 80/90 short strangle pays 1.72/contract at the mid.
Other top implied underlyings include CRON at 140%, IQ at 60%, and NTNX at 54%, but these underlyings aren't the best in terms of expiry and strike availability, which can make for headaches if you need to roll. I've already experienced some of this in a CRON play; there was no November available after the October monthly, so had to roll all the way out to January, which can be a drag if you're less than the patient type ... . I pretty much knew that it could be a headache going in because of oddball expiry availability, but couldn't pass on the juiciness.
On the non-earnings front: "The Brazilian" -- EWZ continues to be frisky (but not quite as frisky as it was) with a rank of 69 and a 30-day of 47%. The November 29/40 short strangle camped out at the 21 delta has a probability of profit of 70%, break evens of 27.35/41.62, and pays 1.65 -- not bad for an extremely liquid $34 underlying.